Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
The company’s Cruise now has double the road for autonomous driving, but many consumers continue to have safety concerns.
The investigation is targeting so-called middlemen that broker deals between hospitals and pharmaceutical companies.
Thousands of gig-economy workers plan to walk out on Wednesday in a bid for higher wages.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.
Diamondback Energy is picking up Endeavor in a deal that will create a $50 billion player in the Permian Basin.
Roku wants its previews to make you feel the same way the movie does.
After a trial run with Peacock, the league will step up to a bigger base of streaming spectators.
To prepare for a slowdown of global trade, US retailers spent months building a massive inventory to prevent empty shelves.
Baidu’s patent to tune up self-driving cars could help its fleet account for crazy drivers.
This year, a slew of unions representing Hollywood’s less heralded below-the-line workers have their turn at the negotiating table
The cost of a 30-second spot is going up, and so is the use of celebrity endorsers.
Canada’s Liberal Party won a majority promising to distance the country from the US, a major importer of Canadian crude.
Investor worries about a fresh batch of US tariffs have dragged LVMH shares in Paris down 23.6% so far this year.
The company plans to seek regulatory approval for the revolutionary weight loss treatment by the end of the year.
The warnings come as the industry adapts to seismic shifts in technology — which means it may just have some new tricks up its sleeve.